Antigen targeting to dendritic cells combined with transient regulatory T cell inhibition results in long-term tumor regression
/in Dendritic Cells, International PublicationsDendritic cell cancer vaccines: from the bench to the bedside
/in Dendritic Cells, International PublicationsOverexpression of heat shock protein 27 (HSP27) increases gemcitabine sensitivity in pancreatic cancer cells through S-phase arrest and apoptosis
/in Hyperthermia, International Publications, Pancreatic CancerEnhancing dendritic cell-based vaccination for highly aggressive glioblastoma
/in Dendritic Cells, Glioblastoma, International PublicationsInhibition of cell proliferation by mild hyperthermia at 43˚C with Paris Saponin I in the lung adenocarcinoma cell line PC-9
/in Hyperthermia, International Publications, NSCLCApoptotic induction of lung adenocarcinoma A549 cells infected by recombinant RVG Newcastle disease virus (rL-RVG) in vitro
/in International Publications, Newcastle Disease Virus, NSCLCHyperthermia, radiation and chemotherapy: the role of heat in multidisciplinary cancer care
/in Hyperthermia, International PublicationsStrong T‑cell costimulation can reactivate tumor antigen‑specific T cells in late‑stage metastasized colorectal carcinoma patients: results from a phase Ⅰ clinical study
/in International Publications, IOZK Veröffentlichungen, Newcastle Disease VirusLong-term remission of prostate cancer with extensive bone metastases upon immuno- and virotherapy: A case report
/in Dendritic Cells, Hyperthermia, International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus, Prostate Cancer
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer